Aeris Environmental Hard Surface Disinfecting Paper

Monday, 28 February, 2022 | Supplied by: Aeris Environmental Ltd


Addressing the need for eco-friendly, COVID-19-killing solutions, Aeris Environmental has developed 100% biodegradable and renewably sourced paper products for disinfecting hard surfaces.

Single-use disinfectant wipes are used on a large scale in medical settings, hotels and restaurants, schools, universities and more as a preventative measure to fight the spread of COVID-19. Unfortunately, most single-use wipes are made from synthetic fibres that do not break down biologically and can remain in the environment for up to 100 years. Fighting COVID-19 and pandemic pollution is Aeris Environmental’s Hard Surface Disinfecting Paper, which is sustainably sourced and 100% biodegradable.

Activated by water, the paper is designed to kill COVID-19 and a broad range of bacteria for hygienic, hospital-grade disinfection of surfaces. The paper’s disinfection qualities also help minimise the risk of cross-infection contamination. The disinfecting paper for hard surfaces is thus a convenient way to deliver hospital-grade hygiene for use across healthcare, aged care and other industries.

With PEFC (Programme for the Endorsement of Forest Certification) certification, the disinfecting paper is sourced from sustainably managed forests and supports responsible forestry for social, ecological and economic good. As a fully biodegradable product, it breaks down to reduce waste that would otherwise end up in landfill, making it an eco-friendly alternative to plastic-based wipes.

Online: www.aeris.com.au
Phone: 02 8344 1315
Related Products

Integrated DNA Technologies xGen Hybridization and Wash v3 Kit

Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...

Cytek Tonbo Reagents

Cytek Tonbo Reagents are designed to enable high-quality research without breaking the budget....

Selleck Chemicals FDA-approved Anticancer Drug Library

Selleck Chemicals (SelleckChem) offers a collection of 1734 approved drugs with potential...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd